This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waters, M.
Right arrow Articles by Sarker, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waters, M.
Right arrow Articles by Sarker, M. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 4002-4009, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4002-4009.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Regulated Expression of the Beta2-Toxin Gene (cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases

Michael Waters,1 Deepa Raju,1 Helen S. Garmory,2 Michel R. Popoff,3 and Mahfuzur R. Sarker1*

Department of Microbiology, Oregon State University, Corvallis, Oregon 97331,1 Department of Biomedical Sciences, Defense Science and Technology Laboratory, Porton Down, Salisbury, SP4 0JQ, United Kingdom,2 Unite des Toxines Microbiennes, Institut Pasteur, 75724 Paris, Cedex 15, France3

Received 7 December 2004/ Returned for modification 13 March 2005/ Accepted 2 May 2005

Recent epidemiological studies suggested that cpb2-positive Clostridium perfringens isolates are associated with gastrointestinal (GI) diseases in horses. These putative relationships, indicated by PCR genotyping, were tested in the present study by further genotyping and phenotyping of 23 cpb2-positive C. perfringens isolates from horses with GI disease (referred to hereafter as horse GI disease isolates). Our beta2-toxin (CPB2) Western blot analyses demonstrated that all of the tested isolates were unable to produce detectable levels of CPB2. However, Southern blot and nucleotide sequencing analyses identified intact cpb2 open reading frames in all of our surveyed horse GI disease isolates. Furthermore, reverse transcriptase PCR and Northern blot analyses showed that cpb2 genes in all of our surveyed horse GI disease isolates were transcriptionally active, i.e., an ~1.2-kb cpb2-specific mRNA was identified in total RNA from our surveyed isolates. The levels of cpb2 mRNA in CWC245 (a high-CPB2-producing pig strain) and our surveyed horse GI disease isolates differed to such an extent (35-fold) that this difference could be considered as a major cause of the difference in levels of CPB2 production by CWC245 and horse GI disease isolates. This finding received further support from our observation that the complementing strain 106902(pMRS140), which produced significantly higher levels of mRNA than strain 106902, produced high levels of CPB2. Collectively, our results indicated that there is a positive correlation between cpb2 transcription levels and the amount of CPB2 produced by a C. perfringens cell and that decreased transcription and/or message instability may be involved, at least in part, in the low CPB2 production noted for horse GI disease isolates in comparison to that noted for pig GI disease isolate CWC245.

* Corresponding author. Mailing address: Department of Microbiology, Oregon State University, Corvallis, OR 97331. Phone: (541) 737-2950. Fax: (541) 737-0496. E-mail: sarkerm{at}oregonstate.edu.

Journal of Clinical Microbiology, August 2005, p. 4002-4009, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4002-4009.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mendez, M., Huang, I-H., Ohtani, K., Grau, R., Shimizu, T., Sarker, M. R. (2008). Carbon Catabolite Repression of Type IV Pilus-Dependent Gliding Motility in the Anaerobic Pathogen Clostridium perfringens. J. Bacteriol. 190: 48-60 [Abstract] [Full Text]  
  • Crespo, R., Fisher, D. J., Shivaprasad, H.L., Fernandez-Miyakawa, M. E., Uzal, F. A. (2007). Toxinotypes of Clostridium Perfringens Isolated from Sick and Healthy Avian Species. jvdi 19: 329-333 [Abstract] [Full Text]  
  • Fernandez-Miyakawa, M. E., Fisher, D. J., Poon, R., Sayeed, S., Adams, V., Rood, J. I., McClane, B. A., Uzal, F. A. (2007). Both Epsilon-Toxin and Beta-Toxin Are Important for the Lethal Properties of Clostridium perfringens Type B Isolates in the Mouse Intravenous Injection Model. Infect. Immun. 75: 1443-1452 [Abstract] [Full Text]  
  • Harrison, B., Raju, D., Garmory, H. S., Brett, M. M., Titball, R. W., Sarker, M. R. (2005). Molecular Characterization of Clostridium perfringens Isolates from Humans with Sporadic Diarrhea: Evidence for Transcriptional Regulation of the Beta2-Toxin-Encoding Gene. Appl. Environ. Microbiol. 71: 8362-8370 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»